← Back
Option Care Health
OPCH · listed on Nasdaq · worth $3.56 billion
$31.26
+0.11% today
One insider buy in the last year, $987.4K in all. None in the last two weeks. One member of Congress reported trading Option Care Health in the last year.
Green dot = an insider bought red = sold◆ = company newsA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
138.7M shares
93% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, one insider bought Option Care Health stock and two insiders sold. None of the 2 sales is marked on its filing as planned in advance. The biggest seller was R. Carter Pate.
How each buyer's earlier purchases went: the stock about six months later, beside the S&P 500 over the same days. Purchases planned in advance are left out. Past results, not a forecast.
Director
Harry M. Jansen Kraemer Jr
Bought $987.4K on Nov 3, 2025 — 38,000 shares at $25.98, 9.2% of what they now own.
1 of 1 earlier purchase did better than the S&P 500
Big investors
People and funds that reported owning 5% or more of Option Care Health, newest first.
Filed by someone who owns 5% or more and does not plan to influence the company. · updateBlackRock13.1%Oct 27
US Congress
Members of Congress who reported trading Option Care Health in the last year. They have up to 45 days to report, so the newest trades show up late.
MemberTradeAmountWhose accountTradedReported
All reports
Every insider trade and SEC report we hold for Option Care Health.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Nov 4, 2025BoughtHarry M. Jansen Kraemer JrNov 4, 2025 · Traded Nov 3, 2025 · Director+9.2%38,000 @ $25.98$987.4K
Sep 10, 2025BoughtNorman L. WrightSep 10, 2025 · Traded Sep 9, 2025 · Director+22%3,411 @ $29.31$100K
3 more with Pro →Analysts, earnings and news
Analysts' price target
$28.58 average
12 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
3 of 4 quarters above
Q2 '26$0.45 a share+$0.02
Q1 '26$0.40 a share+$0.03
Q4 '25$0.46 a share−$0.01
Q3 '25$0.45 a share+$0.02